skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,160  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: resource type: Newsletter Articles remove subject: Net Losses remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Press Release: scPharmaceuticals Inc. Reports -2
Material Type:
Newsletter Article
Add to My Research

Press Release: scPharmaceuticals Inc. Reports -2

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Nov 8, 2023

Digital Resources/Online E-Resources

2
Press Release: scPharmaceuticals Inc. Reports -2
Material Type:
Newsletter Article
Add to My Research

Press Release: scPharmaceuticals Inc. Reports -2

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Aug 10, 2023

Digital Resources/Online E-Resources

3
Press Release: scPharmaceuticals Inc. Reports -2
Material Type:
Newsletter Article
Add to My Research

Press Release: scPharmaceuticals Inc. Reports -2

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. Mar 13, 2024

Digital Resources/Online E-Resources

4
BioCardia (BCDA: 39.90c) inches higher, resistance at 12-day EMA; +0.9c [2.3%]
Material Type:
Newsletter Article
Add to My Research

BioCardia (BCDA: 39.90c) inches higher, resistance at 12-day EMA; +0.9c [2.3%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Nov 13, 2023

Digital Resources/Online E-Resources

5
BioCardia (BCDA: 39.0c) sinks 4.9% weakening below moving average price; -2c [-4.9%]
Material Type:
Newsletter Article
Add to My Research

BioCardia (BCDA: 39.0c) sinks 4.9% weakening below moving average price; -2c [-4.9%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Nov 10, 2023

Digital Resources/Online E-Resources

6
BioCardia (BCDA: 41.0c) tumbles 5.7% on average volume, reports 730% sequential rise in Quarterly Revenue; -2.5c [-5.7%]
Material Type:
Newsletter Article
Add to My Research

BioCardia (BCDA: 41.0c) tumbles 5.7% on average volume, reports 730% sequential rise in Quarterly Revenue; -2.5c [-5.7%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Nov 9, 2023

Digital Resources/Online E-Resources

7
Cytokinetics (CYTK: $37.05) price 5.1% below VWAP on strong volume
Material Type:
Newsletter Article
Add to My Research

Cytokinetics (CYTK: $37.05) price 5.1% below VWAP on strong volume

News Bites US - NASDAQ, 2021

Copyright News Bites Pty Ltd Dec 8, 2021

Digital Resources/Online E-Resources

8
Cytokinetics (CYTK: $37.47) lifts 3.6% strengthening above moving average price
Material Type:
Newsletter Article
Add to My Research

Cytokinetics (CYTK: $37.47) lifts 3.6% strengthening above moving average price

News Bites US - NASDAQ, 2021

Copyright News Bites Pty Ltd Dec 7, 2021

Digital Resources/Online E-Resources

9
Lexicon Pharmaceuticals Stock Jumps on 4Q Revenue, Sotagliflozin Heart Drug Update
Material Type:
Newsletter Article
Add to My Research

Lexicon Pharmaceuticals Stock Jumps on 4Q Revenue, Sotagliflozin Heart Drug Update

Dow Jones Institutional News, 2023

Copyright Dow Jones & Company Inc. Mar 3, 2023

Digital Resources/Online E-Resources

10
Monthly: Nuwellis (NUWE: 54.0c) plunges 14%, 2 months' volume in a month
Material Type:
Newsletter Article
Add to My Research

Monthly: Nuwellis (NUWE: 54.0c) plunges 14%, 2 months' volume in a month

News Bites US - NASDAQ, 2022

Copyright News Bites Pty Ltd Oct 1, 2022

Digital Resources/Online E-Resources

11
Press Release: Cytokinetics Reports First Quarter -2
Material Type:
Newsletter Article
Add to My Research

Press Release: Cytokinetics Reports First Quarter -2

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. May 8, 2024

Digital Resources/Online E-Resources

12
Monthly: Applied Therapeutics (APLT: $4.42) plummets 35% on thin volume in April 2024
Material Type:
Newsletter Article
Add to My Research

Monthly: Applied Therapeutics (APLT: $4.42) plummets 35% on thin volume in April 2024

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 1, 2024

Digital Resources/Online E-Resources

13
Monthly: scPharmaceuticals (SCPH: $4.47) falls a second month, trailing 74% of stocks
Material Type:
Newsletter Article
Add to My Research

Monthly: scPharmaceuticals (SCPH: $4.47) falls a second month, trailing 74% of stocks

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 1, 2024

Digital Resources/Online E-Resources

14
Press Release: CVRx Reports First Quarter 2024 Financial and Operating Results
Material Type:
Newsletter Article
Add to My Research

Press Release: CVRx Reports First Quarter 2024 Financial and Operating Results

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. Apr 30, 2024

Digital Resources/Online E-Resources

15
Press Release: CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024
Material Type:
Newsletter Article
Add to My Research

Press Release: CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. Apr 24, 2024

Digital Resources/Online E-Resources

16
Press Release: CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Material Type:
Newsletter Article
Add to My Research

Press Release: CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Dow Jones Institutional News, 2024

Copyright Dow Jones & Company Inc. Jan 25, 2024

Digital Resources/Online E-Resources

17
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Material Type:
Newsletter Article
Add to My Research

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

NASDAQ OMX's News Release Distribution Channel, 2024

GlobeNewswire, Inc.

Digital Resources/Online E-Resources

18
BioCardia (BCDA: 63.0c) tumbles 6.3% weakening below moving average price; -4.23c [-6.3%]
Material Type:
Newsletter Article
Add to My Research

BioCardia (BCDA: 63.0c) tumbles 6.3% weakening below moving average price; -4.23c [-6.3%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Dec 4, 2023

Digital Resources/Online E-Resources

19
BioCardia (BCDA: 67.0c) surges 7.9% on rising relative strength; +4.88c [7.9%]
Material Type:
Newsletter Article
Add to My Research

BioCardia (BCDA: 67.0c) surges 7.9% on rising relative strength; +4.88c [7.9%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Dec 1, 2023

Digital Resources/Online E-Resources

20
Press Release: CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Material Type:
Newsletter Article
Add to My Research

Press Release: CVRx Reports Fourth Quarter and Full Year 2021 Financial and Operating Results

Dow Jones Institutional News, 2022

Copyright Dow Jones & Company Inc Feb 15, 2022

Digital Resources/Online E-Resources

Results 1 - 20 of 3,160  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2004  (32)
  2. 2004 To 2008  (170)
  3. 2009 To 2013  (198)
  4. 2014 To 2019  (458)
  5. After 2019  (2,303)
  6. More options open sub menu

Searching Remote Databases, Please Wait